From April 1, 2024 to April 18, 2024, the company has repurchased 3,857,300 shares, representing 0.32% for CNY 29.28 million. With this, the company has completed the repurchase of 11,687,200 shares, representing 0.98% for CNY 98.99 million under the buyback announced on December 23, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.12 CNY | -0.12% | -5.03% | -13.25% |
May. 20 | Hisun Pharma's Veterinary Arm Gets Approval to Register Amoxicillin and Clavulanate Potassium Dry Suspension | MT |
May. 16 | Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.25% | 1.32B | |
+37.36% | 723B | |
+32.22% | 598B | |
-2.01% | 364B | |
+20.20% | 331B | |
+2.79% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+8.73% | 169B |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.